Oral vs intravenous fluoropyrimidines
Hand‐foot syndrome (grade ≥ 3) · Patients treated with curative intent for colorectal cancer with neoadjuvant and/or adjuvant chemotherapy
Oral may leads to higher grade ≥ 3 hand foot syndrome compared with intravenous fluoropyrimidines (low certainty).
1 finding from 1 review
- Oral versus intravenous fluoropyrimidines for colorectal cancer 2017 · Cochrane Headline outcomes onlyOR 4.59 [2.97, 7.1]5 studies · 5731 participantsLow